These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 32071854)

  • 21. E-cigarette or vaping product use-associated acute lung injury (EVALI) as a therapeutic problem in anaesthesiology and intensive care departments.
    Bizoń M; Maciejewski D; Kolonko J
    Anaesthesiol Intensive Ther; 2020; 52(3):219-225. PubMed ID: 32876409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaping-Associated Acute Respiratory Failure Due to Acute Lipoid Pneumonia.
    Dicpinigaitis PV; Trachuk P; Fakier F; Teka M; Suhrland MJ
    Lung; 2020 Feb; 198(1):31-33. PubMed ID: 31583455
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diffuse Alveolar Hemorrhage: An Uncommon Manifestation of Vaping-associated Lung Injury.
    Wilhite R; Patel T; Karle E; Shankar S; Krvavac A
    Cureus; 2019 Dec; 11(12):e6519. PubMed ID: 32025438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Demographics, Substance Use Behaviors, and Clinical Characteristics of Adolescents With e-Cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI) in the United States in 2019.
    Adkins SH; Anderson KN; Goodman AB; Twentyman E; Danielson ML; Kimball A; Click ES; Ko JY; Evans ME; Weissman DN; Melstrom P; Kiernan E; Krishnasamy V; Rose DA; Jones CM; King BA; Ellington SR; Pollack LA; Wiltz JL;
    JAMA Pediatr; 2020 Jul; 174(7):e200756. PubMed ID: 32421164
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrahydrocannabinol (THC)-containing e-cigarette, or vaping, product use behaviors among adults after the onset of the 2019 outbreak of e-cigarette, or vaping, product use-associated lung injury (EVALI).
    Trivers KF; Watson CV; Neff LJ; Jones CM; Hacker K
    Addict Behav; 2021 Oct; 121():106990. PubMed ID: 34087764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update: Characteristics of a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020.
    Krishnasamy VP; Hallowell BD; Ko JY; Board A; Hartnett KP; Salvatore PP; Danielson M; Kite-Powell A; Twentyman E; Kim L; Cyrus A; Wallace M; Melstrom P; Haag B; King BA; Briss P; Jones CM; Pollack LA; Ellington S;
    MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(3):90-94. PubMed ID: 31971931
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update: Product, Substance-Use, and Demographic Characteristics of Hospitalized Patients in a Nationwide Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - United States, August 2019-January 2020.
    Ellington S; Salvatore PP; Ko J; Danielson M; Kim L; Cyrus A; Wallace M; Board A; Krishnasamy V; King BA; Rose D; Jones CM; Pollack LA;
    MMWR Morb Mortal Wkly Rep; 2020 Jan; 69(2):44-49. PubMed ID: 31945038
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electronic Cigarette or Vaping Product Use-Associated Lung Injury in a Previously Healthy Young Male.
    Ismail AS; Imaduddeen T; Ibrahim WH
    Cureus; 2021 Sep; 13(9):e18269. PubMed ID: 34722048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe Lung Injury Associated With Use of e-Cigarette, or Vaping, Products-California, 2019.
    Heinzerling A; Armatas C; Karmarkar E; Attfield K; Guo W; Wang Y; Vrdoljak G; Moezzi B; Xu D; Wagner J; Fowles J; Dean C; Cummings KJ; Wilken JA
    JAMA Intern Med; 2020 Jun; 180(6):861-869. PubMed ID: 32142111
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute eosinophilic pneumonia following inhalation of turpentine oil: A case report.
    Umekage Y; Okumura S; Tenma T; Kazebayashi Y; Hirai N; Minami Y; Doshita K; Sasaki T; Yamamoto Y; Ohsaki Y
    Respir Med Case Rep; 2020; 31():101143. PubMed ID: 32676278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaping Aerosols from Vitamin E Acetate and Tetrahydrocannabinol Oil: Chemistry and Composition.
    Li Y; Dai J; Tran LN; Pinkerton KE; Spindel ER; Nguyen TB
    Chem Res Toxicol; 2022 Jun; 35(6):1095-1109. PubMed ID: 35559605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury-North Carolina, 2019.
    Tanz LJ; Christensen A; Knuth KB; Hoffman MN; Dandeneau D; Koehler K; Moore Z; Herndon S; Davidson K; Fleischauer A
    N C Med J; 2021; 82(6):384-392. PubMed ID: 34750211
    [No Abstract]   [Full Text] [Related]  

  • 33. Vaping-induced diffuse alveolar hemorrhage.
    Edmonds PJ; Copeland C; Conger A; Richmond BW
    Respir Med Case Rep; 2020; 29():100996. PubMed ID: 31956478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. E-cigarette or vaping product use-associated lung injury: A review of clinico-radio-pathological characteristics.
    Garg I; Vidholia A; Garg A; Singh S; Agahi A; Laroia A; Saboo SS; Comellas AP; Hoffman EA; Nagpal P
    Respir Investig; 2022 Nov; 60(6):738-749. PubMed ID: 35963780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid Development and Validation of a Liquid Chromatography-Tandem Mass Spectrometry Method to Measure Cannabinoids in Bronchoalveolar-Lavage Fluid of Patients with e-Cigarette, or Vaping, Product Use-Associated Lung Injury.
    Brosius CR; Caron KT; Sosnoff CS; Blount BC; Wang L
    ACS Omega; 2022 Jan; 7(1):443-452. PubMed ID: 35036713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Bronchoalveolar Lavage Fluid from Patients in an Outbreak of E-cigarette, or Vaping, Product Use-Associated Lung Injury - 10 States, August-October 2019.
    Blount BC; Karwowski MP; Morel-Espinosa M; Rees J; Sosnoff C; Cowan E; Gardner M; Wang L; Valentin-Blasini L; Silva L; De Jesús VR; Kuklenyik Z; Watson C; Seyler T; Xia B; Chambers D; Briss P; King BA; Delaney L; Jones CM; Baldwin GT; Barr JR; Thomas J; Pirkle JL
    MMWR Morb Mortal Wkly Rep; 2019 Nov; 68(45):1040-1041. PubMed ID: 31725707
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel methods for the analysis of toxicants in bronchoalveolar lavage fluid samples from e-cigarette, or vaping, product use-associated lung injury cases: Selected petroleum distillates.
    De Jesús VR; Chambers DM; Reese C; Braselton M; Espinosa P; Corstvet J; Blount BC
    Rapid Commun Mass Spectrom; 2020 Oct; 34(19):e8898. PubMed ID: 32672382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. E-cigarette or Vaping Product Use-Associated Lung Injury Produced in an Animal Model From Electronic Cigarette Vapor Exposure Without Tetrahydrocannabinol or Vitamin E Oil.
    Kleinman MT; Arechavala RJ; Herman D; Shi J; Hasen I; Ting A; Dai W; Carreno J; Chavez J; Zhao L; Kloner RA
    J Am Heart Assoc; 2020 Sep; 9(18):e017368. PubMed ID: 32896206
    [TBL] [Abstract][Full Text] [Related]  

  • 39. E-cigarette or vaping product use-associated lung injury.
    Ind PW
    Br J Hosp Med (Lond); 2020 Apr; 81(4):1-9. PubMed ID: 32339005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaping-associated acute respiratory distress syndrome.
    Sakla NM; Gattu R; Singh G; Sadler M
    Emerg Radiol; 2020 Feb; 27(1):103-106. PubMed ID: 31820270
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.